BioSig Technologies Stock Price, News & Analysis (OTCMKTS:BSGM)

$1.38 0.00 (0.00 %)
(As of 02/20/2018 02:32 PM ET)
Previous Close$1.38
Today's Range$1.38 - $1.48
52-Week Range$1.20 - $2.00
Volume19,940 shs
Average Volume42,635 shs
Market Capitalization$39.59 million
P/E Ratio-3.56
Dividend YieldN/A
Beta0.65

About BioSig Technologies (OTCMKTS:BSGM)

BioSig Technologies logoBioSig Technologies, Inc. is a development-stage medical device company. The Company is developing a technology platform to manage noise and artifacts from cardiac recordings during electrophysiology studies and ablation. It is engaged in developing the Precise Uninterrupted Real-time evaluation of Electrograms (PURE) electro-pneumatic (EP) System. PURE EP System is a surface electrocardiogram and intracardiac multichannel recording and analysis system that acquires, processes and displays electrocardiogram and electrograms required during electrophysiology studies and ablation procedures. The Company's PURE EP System is designed to assist electrophysiologists with real-time evaluations of electrocardiograms and electrograms, and helps in making clinical decisions in real-time. It is also developing signal-processing tools, which will assist electrophysiologists in differentiating true signals from noise and provide guidance in identifying ablation targets within the PURE EP System.

Receive BSGM News and Ratings via Email

Sign-up to receive the latest news and ratings for BSGM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:BSGM
CUSIPN/A
Phone310-820-8100

Debt

Debt-to-Equity RatioN/A
Current Ratio0.09%
Quick Ratio0.09%

Price-To-Earnings

Trailing P/E Ratio-3.56410256410256
Forward P/E Ratio-3.37
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book Value($0.13) per share
Price / Book-10.62

Profitability

Trailing EPS($0.39)
Net Income$-11,580,000.00
Net MarginsN/A
Return on EquityN/A
Return on Assets-907.33%

Miscellaneous

Employees11
Outstanding Shares28,690,000

BioSig Technologies (OTCMKTS:BSGM) Frequently Asked Questions

What is BioSig Technologies' stock symbol?

BioSig Technologies trades on the OTCMKTS under the ticker symbol "BSGM."

How were BioSig Technologies' earnings last quarter?

BioSig Technologies Inc (OTCMKTS:BSGM) announced its quarterly earnings data on Friday, August, 12th. The company reported ($0.32) earnings per share for the quarter. View BioSig Technologies' Earnings History.

Who are some of BioSig Technologies' key competitors?

Who are BioSig Technologies' key executives?

BioSig Technologies' management team includes the folowing people:

  • Kenneth L. Londoner, Executive Chairman of the Board, Chief Executive Officer (Age 50)
  • Steven Chaussy, Chief Financial Officer (Age 63)
  • Natasha Russkina, Vice President, Business Development and Corporate Finance
  • Joseph W. Rafferty, Chief Commercialization Officer (Age 59)
  • Andrew Filler J.D. Esq., Director
  • Seth H. Z. Fischer, Independent Director (Age 61)
  • Donald E. Foley, Independent Director (Age 65)
  • Patrick J. Gallagher, Independent Director (Age 52)
  • Jeffrey F. O'Donnell Sr., Independent Director (Age 57)

How do I buy BioSig Technologies stock?

Shares of BioSig Technologies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is BioSig Technologies' stock price today?

One share of BioSig Technologies stock can currently be purchased for approximately $1.38.

How big of a company is BioSig Technologies?

BioSig Technologies has a market capitalization of $39.59 million. The company earns $-11,580,000.00 in net income (profit) each year or ($0.39) on an earnings per share basis. BioSig Technologies employs 11 workers across the globe.

How can I contact BioSig Technologies?

BioSig Technologies' mailing address is 12424 WILSHIRE BLVD SUITE 745, LOS ANGELES CA, 90025. The company can be reached via phone at 310-820-8100 or via email at [email protected]


MarketBeat Community Rating for BioSig Technologies (BSGM)

Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  34 (Vote Outperform)
Underperform Votes:  58 (Vote Underperform)
Total Votes:  92
MarketBeat's community ratings are surveys of what our community members think about BioSig Technologies and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

BioSig Technologies (OTCMKTS:BSGM) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyN/A
Consensus Rating Score: 3.003.003.00N/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

BioSig Technologies (OTCMKTS:BSGM) Consensus Price Target History

Price Target History for BioSig Technologies (OTCMKTS:BSGM)

BioSig Technologies (OTCMKTS:BSGM) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
10/1/2017Chardan CapitalReiterated RatingBuyView Rating Details
(Data available from 2/20/2016 forward)

Earnings

BioSig Technologies (OTCMKTS:BSGM) Earnings History and Estimates Chart

Earnings by Quarter for BioSig Technologies (OTCMKTS:BSGM)

BioSig Technologies (OTCMKTS BSGM) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/10/2017Q2 2017($0.12)ViewN/AView Earnings Details
5/9/2017Q1 2017($0.14)ViewN/AView Earnings Details
3/30/2017Q4 2016($0.05)ViewN/AView Earnings Details
11/14/2016Q3 2016($0.08)ViewN/AView Earnings Details
8/12/2016Q2($0.32)ViewN/AView Earnings Details
5/4/2016Q1 2016($0.15)ViewN/AView Earnings Details
3/14/2016Q4 2015($0.13)ViewN/AView Earnings Details
11/13/2015Q3 2015($0.17)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

BioSig Technologies (OTCMKTS:BSGM) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.41 EPS
Next Year EPS Consensus Estimate: $-0.35 EPS

Dividends

Dividend History for BioSig Technologies (OTCMKTS:BSGM)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

BioSig Technologies (OTCMKTS BSGM) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 44.87%
Insider Trades by Quarter for BioSig Technologies (OTCMKTS:BSGM)

BioSig Technologies (OTCMKTS BSGM) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/16/2018Kenneth L LondonerCEOSell115,000$0.75$86,250.00View SEC Filing  
1/22/2018Kenneth L LondonerCEOBuy26,600$1.44$38,304.00View SEC Filing  
12/21/2017Steve ChaussyCFOBuy2,500$1.48$3,700.00View SEC Filing  
8/22/2017Steve ChaussyCFOBuy10,425$1.39$14,490.75628,762View SEC Filing  
6/6/2017Lora MikolaitisMajor ShareholderSell200,000$0.75$150,000.0043,750View SEC Filing  
5/19/2016Steve ChaussyCFOBuy400$1.81$724.00423,762View SEC Filing  
4/29/2016Patrick Joseph GallagherDirectorBuy20,000$1.50$30,000.0045,000View SEC Filing  
3/16/2016Kenneth L LondonerDirectorBuy6,500$1.21$7,865.00519,911View SEC Filing  
1/12/2016Steve ChaussyCFOBuy3,000$1.19$3,570.00423,362View SEC Filing  
12/24/2015Steve ChaussyCFOBuy4,000$1.40$5,600.00322,362View SEC Filing  
12/18/2015Steve ChaussyCFOBuy5,000$1.25$6,250.00318,362View SEC Filing  
12/16/2015Steve ChaussyCFOBuy5,000$1.17$5,850.00313,362View SEC Filing  
11/18/2015Donald E FoleyDirectorBuy200,000$1.50$300,000.00200,000View SEC Filing  
10/7/2015Kenneth L LondonerDirectorBuy5,500$1.50$8,250.00768,539View SEC Filing  
10/6/2015Kenneth L. LondonerDirectorBuy17,094$1.49$25,470.06763,039View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

BioSig Technologies (OTCMKTS BSGM) News Headlines

Source:
DateHeadline
BioSig Technologies Inc (BSGM) CEO Sells $86,250.00 in StockBioSig Technologies Inc (BSGM) CEO Sells $86,250.00 in Stock
www.americanbankingnews.com - February 16 at 10:04 PM
BioSig Technologies to Open Operations Center in Austin, TexasBioSig Technologies to Open Operations Center in Austin, Texas
finance.yahoo.com - February 13 at 8:51 AM
BioSig Technologies Inc (BSGM) CEO Kenneth L. Londoner Purchases 26,600 SharesBioSig Technologies Inc (BSGM) CEO Kenneth L. Londoner Purchases 26,600 Shares
www.americanbankingnews.com - January 23 at 3:22 PM
Johnson & Johnson Veteran Chuck Austin To Scale Up BioSig OperationsJohnson & Johnson Veteran Chuck Austin To Scale Up BioSig Operations
finance.yahoo.com - January 9 at 8:40 AM
BIOSIG TECHNOLOGIES COMPLETES PRIVATE PLACEMENTBIOSIG TECHNOLOGIES COMPLETES PRIVATE PLACEMENT
finance.yahoo.com - January 8 at 9:55 AM
BioSig Technologies Appoints New Chief Financial Officer to Facilitate Growth TrajectoryBioSig Technologies Appoints New Chief Financial Officer to Facilitate Growth Trajectory
finance.yahoo.com - January 3 at 8:42 AM
BioSig Technologies (BSGM) Rating Lowered to Hold at Zacks Investment ResearchBioSig Technologies (BSGM) Rating Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - January 2 at 9:10 PM
BioSig Technologies to Present at Digital Medicine & Medtech Showcase at Biotech ShowcaseBioSig Technologies to Present at Digital Medicine & Medtech Showcase at Biotech Showcase
finance.yahoo.com - December 28 at 10:41 AM
SeeThruEquity Issues Update on BioSig Technologies, Inc. (OTCQB: BSGM)SeeThruEquity Issues Update on BioSig Technologies, Inc. (OTCQB: BSGM)
finance.yahoo.com - December 22 at 9:38 AM
BioSig Technologies Issues Shareholder Letter for 2017BioSig Technologies Issues Shareholder Letter for 2017
finance.yahoo.com - December 21 at 8:34 AM
Biosig Technologies (BSGM) Rating Increased to Buy at Zacks Investment ResearchBiosig Technologies (BSGM) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - December 1 at 5:38 PM
BioSig Technologies Is a Near-Term Biotech Catalyst PlayBioSig Technologies Is a Near-Term Biotech Catalyst Play
finance.yahoo.com - November 28 at 5:17 PM
BSGM: Bringing Clarity to Catheter AblationBSGM: Bringing Clarity to Catheter Ablation
finance.yahoo.com - November 16 at 5:12 PM
BioSig Technologies Adds Role of Chief Regulatory and Compliance Officer in Preparation for FDA SubmissionBioSig Technologies Adds Role of Chief Regulatory and Compliance Officer in Preparation for FDA Submission
finance.yahoo.com - November 14 at 5:11 PM
IP veteran Andrew Filler joins BioSig Technologies Board of Directors - GlobeNewswire (press release)IP veteran Andrew Filler joins BioSig Technologies' Board of Directors - GlobeNewswire (press release)
globenewswire.com - November 11 at 4:38 PM
BioSig Technologies to Speak at Digital Silver Forum in Helsinki, Finland on November 28BioSig Technologies to Speak at Digital Silver Forum in Helsinki, Finland on November 28
finance.yahoo.com - November 8 at 7:36 PM
BioSig Technologies Partners with Sherpa Technology Group - GlobeNewswire (press release)BioSig Technologies Partners with Sherpa Technology Group - GlobeNewswire (press release)
globenewswire.com - November 4 at 5:09 AM

SEC Filings

BioSig Technologies (OTCMKTS:BSGM) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

BioSig Technologies (OTCMKTS BSGM) Stock Chart for Tuesday, February, 20, 2018

Loading chart…

This page was last updated on 2/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.